Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
Breast cancer is the most commonly diagnosed cancer in the USA. Although advances in
treatment over the past several decades have significantly improved the outlook for this …
treatment over the past several decades have significantly improved the outlook for this …
Eo771, is it a Well‐Characterized cell line for mouse Mammary cancer model? limit and uncertainty
A Le Naour, A Rossary, MP Vasson - Cancer medicine, 2020 - Wiley Online Library
Among mouse mammary tumor models, syngeneic cell lines present an advantage for the
study of immune response. However, few of these models are well characterized. The tumor …
study of immune response. However, few of these models are well characterized. The tumor …
STING suppresses bone cancer pain via immune and neuronal modulation
Patients with advanced stage cancers frequently suffer from severe pain as a result of bone
metastasis and bone destruction, for which there is no efficacious treatment. Here, using …
metastasis and bone destruction, for which there is no efficacious treatment. Here, using …
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice
A Le Naour, Y Koffi, M Diab, D Le Guennec… - Cancer cell …, 2020 - Springer
Background Despite decades of therapeutic trials, effective diagnosis, many drugs available
and numerous studies on breast cancer, it remains the deadliest cancer in women. In order …
and numerous studies on breast cancer, it remains the deadliest cancer in women. In order …
[HTML][HTML] Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice
L Landini, M Marini, DSM de Araujo, A Romitelli… - Brain, Behavior, and …, 2023 - Elsevier
Abstract Insulin growth factor-1 (IGF-1), an osteoclast-dependent osteolysis biomarker,
contributes to metastatic bone cancer pain (MBCP), but the underlying mechanism is poorly …
contributes to metastatic bone cancer pain (MBCP), but the underlying mechanism is poorly …
Sclerostin blockade promotes bone metastases of Wnt‐responsive breast cancer cells
T Hiraga, K Horibe, M Koide, T Yamashita… - Cancer …, 2023 - Wiley Online Library
The secreted protein sclerostin is primarily produced by osteocytes and suppresses
osteoblast differentiation and function by inhibiting the canonical Wnt signaling pathway …
osteoblast differentiation and function by inhibiting the canonical Wnt signaling pathway …
Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression
DK Mondal, C Xie, GJ Pascal… - Proceedings of the …, 2024 - National Acad Sciences
The complex interplay between malignant cells and the cellular and molecular components
of the tumor stroma is a key aspect of cancer growth and development. These tumor–host …
of the tumor stroma is a key aspect of cancer growth and development. These tumor–host …
Decorin evokes reversible mitochondrial depolarization in carcinoma and vascular endothelial cells
Decorin, a small leucine-rich proteoglycan with multiple biological functions, is known to
evoke autophagy and mitophagy in both endothelial and cancer cells. Here, we investigated …
evoke autophagy and mitophagy in both endothelial and cancer cells. Here, we investigated …
Potential miRNAs for miRNA-based therapeutics in breast cancer
JS Wong, YK Cheah - Non-coding RNA, 2020 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs that can post-transcriptionally regulate
the genes involved in critical cellular processes. The aberrant expressions of oncogenic or …
the genes involved in critical cellular processes. The aberrant expressions of oncogenic or …
Primary tumor-induced immunity suppresses bone metastases of breast cancer in syngeneic immunocompetent mouse models
T Hiraga, D Nishida, K Horibe - Bone, 2024 - Elsevier
The immune system plays a crucial role in cancer development and progression. More than
a century ago, mouse models showed that primary tumors suppressed the growth of newly …
a century ago, mouse models showed that primary tumors suppressed the growth of newly …